Transcript
Sarah Jerfing (0:00)
Foreign.
Ada Saldinger (0:04)
My name is Rumbi Chakamba and you're listening to this Week in Global Development hosted by myself, Ada Saldinger and David Ainswood. I'm joined by Aina Messi and Sarah Jerfing. And this week we'll be digging into the US's new health strategy as well as the updates from COP30. Hi everyone. Welcome to this week's edition of this Week in Global Development. And we're joined by our reporters Ayamat and Sarah. For this edition. I think I'm just gonna jump straight in and go straight to you, Sarah. So we're finding out a little bit more about the new health strategy. You reported on a template that the US might be using to negotiate bilateral deals with countries. And those bilateral deals have started. Can you take us where we are at right now and what we actually know about these agreements that are being negotiated?
Sarah Jerfing (0:47)
Yeah, absolutely. So as you mentioned, the US State Department revealed its new America first strategy in September. And within that strategy, the U.S. government is negotiating these overarching bilateral agreements with countries that have a complete package of health programming. And this is different strategy to previous administrations which leaned more heavily on funneling money to implementing partner NGOs. So the Trump administration has been critical of these NGOs and is planning to more heavily on country government faith based organizations in the private sector. So as you mentioned, we reported on a template of these bilateral agreements and that focus on disease areas like hiv, malaria, tuberculosis, colio and measles. It breaks down how funding responsibilities will shift from the US to partner governments and kind of from their own resources. And there's been kind of broadly a lot of optimism around these agreements as kind of a way to better integrate foreign aid international health systems as opposed to creating siloed approaches and parallel systems. But there have been criticisms as well, such as the State Department's capacity after dismantling USAID and laying off a bunch of global health experts. So as you mentioned kind of there's this group of State Department teams moving around, focusing first on 16 African countries. And we just reported on a speech from a conference in Kigali where a State Department official spoke about how American companies are largely absent from African markets and kind of moving forward, African governments won't be aid recipients, but customers. And he referenced two new US deals with American companies, Gilead and Zipline, as kind of ways that how these deals will demonstrate this new approach in action. Also, I attended the African Population and Health Research center symposium in Nairobi today and heard some interesting reactions to the strategy. One of the speakers said that the strategy is more honest than the US has ever been about its intentions towards global health. And that kind of clarity about intentions might help with negotiations. But there was also discussions about imbalances of power where you have these bilateral agreements as opposed to kind of having a continental approach to negotiate.
